News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kiselak Tomas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Fairmount Funds Management LLC (10% Owner) has filed a Form 4 on Dianthus Therapeutics, Inc. /DE/|
Txns:
| Bought 24,670 shares
@ $13.63, valued at
$336.3k
|
|
| 09/28/2023 |
4
| Fairmount Funds Management LLC (10% Owner) has filed a Form 4 on Dianthus Therapeutics, Inc. /DE/|
Txns:
| Bought 30,000 shares
@ $13.15, valued at
$394.5k
|
|
| 07/17/2023 |
4
| Fairmount Funds Management LLC (Director) has filed a Form 4 on Apogee Therapeutics, Inc.|
Txns:
| Bought 55,913 shares
@ $17, valued at
$950.5k
Bought 1,992,734 shares
@ $17, valued at
$33.9M
Bought 892,529 shares
@ $17, valued at
$15.2M
Granted 47,758 options to buy
@ $17, valued at
$811.9k
|
|
| 06/16/2023 |
4
| Kiselak Tomas (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 20,000 options to buy
@ $27.67, valued at
$553.4k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/29/2020 |
4
| Kiselak Tomas (Director) has filed a Form 4 on MIRAGEN THERAPEUTICS, INC.|
Txns:
| Granted 24,000 options to buy
@ $0.5199, valued at
$12.5k
|
|
|
|